GTPBP1 and infection: The EBOV GP1,2 stalk–MPER is of interest for therapeutic/vaccine design due to its relatively high amino acid sequence conservation among all orthoebolaviruses, indicating that a single mAb targeting this region could have therapeutic activity against infections by any of these viruses.